| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry [K. G. B., B. W. C., M. S.], Fidia-Georgetown Institute of the Neuroscience [M. D.], Georgetown University School of Medicine, Washington, DC 20007; Pediatric Branch [I. T. M., J. N.], Laboratories of Pathology [J. C.] and Genetics [K. H.], National Cancer Institute, NIH, Bethesda, Maryland 20892; Department of Medical Oncology, Lombardi Cancer Center, Georgetown University Hospital, Washington, DC 20007 [E. S.]; NCl/Navy Medical Oncology Branch, Naval Hospital, Bethesda, Maryland 20892 [B. J.]; Department of Oncology, Howard University Cancer Center, Washington, DC 20060 [B. G., G. B.]
The nuclear enzyme poly(ADP-ribose) polymerase (PADPRP) is thought to play a role in DNA recombination, replication, and repair. In view of the implication of these processes in tumorigenesis, and based on preliminary evidence which indicated the presence of an extraneous polymorphic restriction fragment for murine PADPRP loci in strains of mice susceptible to plasmacytomas, we investigated correlations between the restriction fragment length polymorphism of the PADPRP gene(s) and human Burkitt lymphoma. No increase in the frequency of polymorphisms on chromosome 1 (containing the active gene) or on chromosome 14 (a pseudogene) was observed. However, restriction fragment length polymorphism analysis of PADPRP sequences on chromosome 13 (either a processed pseudogene or a gene with extensive identity to PADPRP) revealed that of 19 DNA samples derived from endemic Burkitt lymphoma all contained at least one copy of a rare allele (B). Simple two-allele (A/B) polymorphisms in this PADPRP-like locus were identified by digestion with a number of restriction enzymes including HindIII, PstI, KpnI, and MspI. These restriction fragment length polymorphisms always segregated together, suggesting that they identify a deletion within or close to the PADPRP sequences on chromosome 13, which we mapped precisely to 13q33-qter. Based upon family studies the A and B alleles were shown to be transferred in a Mendelian codominant fashion. Subsequently, this probe was used as a linkage marker to study the frequency of this deletion in various tumors including B-cell follicular lymphomas, small cell lung carcinomas, breast carcinomas, and colorectal carcinomas. In noncancer control populations, the frequency of this deletion was 3-fold higher among Blacks as compared to Caucasians. When DNA from various tumors was compared to normal DNA from racially appropriate noncancer controls, the frequency of this deletion was still 2- to 3-fold higher in the tumor DNA. Matched samples provided instances of tumor-specific loss of heterozygosity but also revealed that the predominant source of this delection is the germ line, suggesting that the chromosome 13 region neighboring the PADPRP locus may harbor a gene whose loss may predispose individuals to malignancy.
1 This work was supported by Grants CA25344 and CA13195 from the National Cancer Institute, and by a grant from the United States Air Force Office of Scientific Research.
2 To whom requests for reprints should be addressed, at Department of Biochemistry and Molecular Biology, Georgetown University Medical School, 3900 Reservoir Road NW, Washington, DC 20007-2197.
Received 12/19/89.
Revised 4/25/90.
This article has been cited by other articles:
![]() |
C. M. Simbulan-Rosenthal, B. R. Haddad, D. S. Rosenthal, Z. Weaver, A. Coleman, R. Luo, H. M. Young, Z.-Q. Wang, T. Ried, and M. E. Smulson Chromosomal aberrations in PARP-/- mice: Genome stabilization in immortalized cells by reintroduction of poly(ADP-ribose) polymerase cDNA PNAS, November 9, 1999; 96(23): 13191 - 13196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gu, M. R. Spitz, F. Yang, and X. Wu Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk Carcinogenesis, August 1, 1999; 20(8): 1465 - 1470. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |